|
Volumn 79, Issue 2, 2005, Pages 133-134
|
Tolerance or accommodation: The lesson from leflunomide
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COMPLEMENT;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
HEME OXYGENASE 1;
LEFLUNOMIDE;
PROTEIN BCL 2;
PROTEIN BCL XL;
ACUTE GRAFT REJECTION;
B LYMPHOCYTE;
CARDIAC GRAFT REJECTION;
COMPLEMENT INHIBITION;
DRUG ACTIVITY;
DRUG MECHANISM;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
HUMAN;
HUMORAL IMMUNITY;
LYMPHOCYTE FUNCTION;
NONHUMAN;
NOTE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
T LYMPHOCYTE;
TRANSPLANTATION TOLERANCE;
VASCULARIZATION;
XENOTRANSPLANTATION;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
ISOXAZOLES;
TRANSPLANTATION IMMUNOLOGY;
|
EID: 12744280868
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1097/01.TP.0000147463.92625.14 Document Type: Note |
Times cited : (3)
|
References (7)
|